Journal: Science Advances
Article Title: CD8 + T cell–derived CD40L mediates noncanonical cytotoxicity in CD40-expressing cancer cells
doi: 10.1126/sciadv.adr9331
Figure Lengend Snippet: ( A ) Histograms represent the CD40 expression on EJ138 or A704 transfected with nontargeting single guide RNA (black, sgNon) or cells depleted for CD40 by CRISPR-Cas9 and sgRNA against human CD40 (red). Gray-filled histograms show isotype staining. ( B ) sgNon (black) or caspase-8 sgRNA–treated (red) EJ138 and A704 cells were treated with multimeric CD40L for 24 hours, and caspase-8 activation was monitored by FITC-IETD-FMK staining. Gray-filled histograms represent the basal caspase-8 activation of unstimulated WT cells. ( C and D ) sgNon, CD40 sgRNA-, or caspase-8 (Casp8) sgRNA–treated variants of EJ138 (C) or A704 (D) were cocultivated with CD40L-enriched CD8 + T cells for 24 hours, and apoptosis was detected by annexin V and DAPI staining. Shown are representative dot plots with frequencies of technical triplicates (left) and bar graphs summarizing the data from experiments with eight different T cell donors. Statistical analysis: [(C) and (D)] Repeated measures ANOVA, followed by Dunnett’s test: ** P < 0.01, *** P < 0.001, and **** P < 0.0001.
Article Snippet: Subsequently, 5 × 10 4 cancer cells were plated in 96-well flat-bottom plates in phenol red–free DMEM supplemented with 1% FBS (Merck), penicillin (100 U/ml), and streptomycin (0.1 mg/ml; PAA) and cultured with or without human multimeric CD40L (10 μg/ml; Miltenyi Biotec) for 48 hours.
Techniques: Expressing, Transfection, CRISPR, Staining, Activation Assay